Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence-based path to newborn screening for Duchenne muscular dystrophy.

Annals of neurology - 1 Mar 2012

Mendell Jerry R, Shilling Chris, Leslie Nancy D, Flanigan Kevin M, al-Dahhak Roula, Gastier-Foster Julie, Kneile Kelley, Dunn Diane M, Duval Brett, Aoyagi Alexander, Hamil Cindy, Mahmoud Maha, Roush Kandice, Bird Lauren, Rankin Chelsea, Lilly Heather, Street Natalie, Chandrasekar Ram, Weiss Robert B

Abstract excerpt

OBJECTIVE: Creatine kinase (CK) levels are increased on dried blood spots in newborns related to the birthing process. As a marker for newborn screening, CK in Duchenne muscular dystrophy (DMD) results in false-positive testing. In this report, we introduce a 2-tier system using the dried blood s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Evidence-Based Medicine
Share to DYSF gene

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to FKRP gene

Share to Infant, Newborn

Share to Muscular Dystrophy, Duchenne

Share to Mutation

Share to Neonatal Screening

Share to Pilot Projects

Source

Identifiers

PMID: 22451200
DOI: 10.1002/ana.23528

Genes

DMD
DYSF
FKRP
SGCB

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22451200-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence-based path to newborn screening for Duchenne muscular dystrophy.PMID 22451200Read ↗

Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening AdoptionSemantic proximity Read ↗

Report of MDA muscle disease symposium on newborn screening for Duchenne muscular dystrophySemantic proximity Read ↗

A pilot study of newborn screening for Duchenne muscular dystrophy in GuangzhouSemantic proximity Read ↗

Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP® Neonatal Creatine Kinase-MM Kit in a US and Danish PopulationSemantic proximity Read ↗

Newborn screening for Duchenne muscular dystrophy‐early detection and diagnostic algorithm for female carriers of Duchenne muscular dystrophySemantic proximity Read ↗

Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China.Semantic proximity Read ↗

Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): case definition in surveillance for childhood-onset Duchenne/Becker muscular dystrophy.Semantic proximity Read ↗

Population-Based Prevalence of Myotonic Dystrophy Type 1 Using Genetic Analysis of Statewide Blood Screening ProgramSemantic proximity Read ↗

Newborn screening of duchenne muscular dystrophy specifically targeting deletions amenable to exon-skipping therapy.Semantic proximity Read ↗

Consensus recommendations for the classification and long-term follow up of infants who screen positive for Krabbe Disease.Semantic proximity Read ↗

Incidence of Duchenne muscular dystrophy in the modern era; an Australian studySemantic proximity Read ↗

Lessons learned from the first national population-based genetic carrier-screening program for Duchenne muscular dystrophy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.